Gamble Institute of Medical Research Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1983
NCT00000585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1983

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

procaine benzylpenicillin (novocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 3)

Hematologic Diseases (Phase 3)

Hemoglobinopathies (Phase 3)

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1